- Home
- AZI vs CING Comparison
AZI vs CING Comparison
Compare AZI & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZI
- CING
- Stock Information
- Founded
- AZI 2010
- CING 2012
- Country
- AZI China
- CING United States
- Employees
- AZI N/A
- CING N/A
- Industry
- AZI
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- AZI
- CING Health Care
- Exchange
- AZI Nasdaq
- CING Nasdaq
- Market Cap
- AZI 25.2M
- CING 22.0M
- IPO Year
- AZI 2024
- CING 2021
- Fundamental
- Price
- AZI $0.21
- CING $3.91
- Analyst Decision
- AZI
- CING Strong Buy
- Analyst Count
- AZI 0
- CING 4
- Target Price
- AZI N/A
- CING $31.00
- AVG Volume (30 Days)
- AZI 3.5M
- CING 153.3K
- Earning Date
- AZI 01-01-0001
- CING 11-06-2025
- Dividend Yield
- AZI N/A
- CING N/A
- EPS Growth
- AZI N/A
- CING N/A
- EPS
- AZI N/A
- CING N/A
- Revenue
- AZI $156,466,000.00
- CING N/A
- Revenue This Year
- AZI N/A
- CING N/A
- Revenue Next Year
- AZI N/A
- CING N/A
- P/E Ratio
- AZI N/A
- CING N/A
- Revenue Growth
- AZI 32.90
- CING N/A
- 52 Week Low
- AZI $0.18
- CING $3.02
- 52 Week High
- AZI $3.20
- CING $6.01
- Technical
- Relative Strength Index (RSI)
- AZI 45.82
- CING 50.03
- Support Level
- AZI $0.20
- CING $3.46
- Resistance Level
- AZI $0.21
- CING $3.89
- Average True Range (ATR)
- AZI 0.02
- CING 0.21
- MACD
- AZI 0.00
- CING 0.04
- Stochastic Oscillator
- AZI 38.40
- CING 74.50
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.